| treatment_phases | |
| Balance of supply (including switching formulation) where the full duration of treatment available under a particular treatment phase was not requested in the preceding prescription | |
| Balance of supply for Initial treatment - Initial 1 (new patient) or Initial 2 (retrial or recommencement of treatment after a break of less than 12 months) or Initial 3 (recommencement of treatment after a break of more than 12 months) | |
| Balance of supply for Initial treatment - Initial 1 (new patient) or Initial 2 (retrial or recommencement of treatment after a break of less than 12 months) or Initial 3 (recommencement of treatment after a break of more than 12 months) - in a patient of any weight being administered a subcutaneous form of this biological medicine | |
| "Balance of supply for Initial treatment, Continuing treatment - subcutaneous form" | |
| Continuing Treatment - balance of supply | |
| Continuing or recommencement of treatment (within 12 months of a treatment break) | |
| Continuing treatment | |
| Continuing treatment - balance of supply | |
| Continuing treatment in a patient weighing at least 30 kg | |
| Continuing treatment in a patient weighing less than 30 kg | |
| Continuing treatment with subcutaneous form or switching from intravenous form to subcutaneous form | |
| First Continuing treatment | |
| First Continuing treatment - balance of supply | |
| First continuing treatment | |
| First continuing treatment - balance of supply | |
| "Initial 1 (New patient), Initial 2 (Change or re-commencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply" | |
| "Initial 1 (New patient), Initial 2 (Change or re-commencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply" | |
| "Initial 1 (New patient), Initial 2 (Change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply" | |
| Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply | |
| Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply | |
| Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply | |
| Initial treatment | |
| Initial treatment - Initial 1 (New patient) | |
| Initial treatment - Initial 1 (new patient weighing at least 30 kg) | |
| Initial treatment - Initial 1 (new patient weighing less than 30 kg) | |
| Initial treatment - Initial 1 (new patient) | |
| Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) - balance of supply | |
| Initial treatment - Initial 1 (new patient) or Initial 2 (change or recommencement of treatment after break of less than 24 months) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) - balance of supply | |
| "Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply" | |
| "Initial treatment - Initial 1 (new patient), Initial 2 (change or recommencement of treatment after a break in medicine of less than 5 years) or Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) - balance of supply" | |
| Initial treatment - Initial 2 (Change or re-commencement of treatment after a break in biological medicine of less than 5 years) | |
| Initial treatment - Initial 2 (Change or re-commencement of treatment after a break of less than 5 years) | |
| Initial treatment - Initial 2 (Change or recommencement of treatment after a break in biological medicine of less than 5 years) | |
| Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 12 months) | |
| Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 24 months) | |
| Initial treatment - Initial 2 (change or recommencement of treatment after a break in biological medicine of less than 5 years) | |
| Initial treatment - Initial 2 (change or recommencement of treatment after a break in in biological medicine of less than 5 years) | |
| Initial treatment - Initial 2 (change or recommencement of treatment after break in biological medicine of less than 24 months) | |
| Initial treatment - Initial 2 (retrial or recommencement of treatment after a break of less than 12 months in a patient weighing at least 30 kg) | |
| Initial treatment - Initial 2 (retrial or recommencement of treatment after a break of less than 12 months in a patient weighing less than 30 kg) | |
| Initial treatment - Initial 2 (retrial or recommencement of treatment after a break of less than 12 months) | |
| Initial treatment - Initial 3 (Recommencement of treatment after a break in biological medicine of more than 5 years) | |
| Initial treatment - Initial 3 (recommencement of a new treatment cycle after a break of more than 12 months in a patient weighing less than 30 kg) | |
| Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 12 months) | |
| Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 24 months) | |
| Initial treatment - Initial 3 (recommencement of treatment after a break in biological medicine of more than 5 years) | |
| Initial treatment - Initial 3 (recommencement of treatment after a break of more than 12 months in a patient weighing at least 30 kg) | |
| Initial treatment - Initial 3 (recommencement of treatment after a break of more than 12 months) | |
| Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilizumab after resolution of the critical shortage of tocilizumab) | |
| Initial treatment - Initial 4 (Temporary listing - change of treatment from another biological medicine to tocilzumab after resolution of the critical shortage of tocilizumab) | |
| Initial treatment with the subcutaneous form where a concurrent PBS authority application for the intravenously (IV) administered formulation is being made | |
| Subsequent continuing treatment | |
| Transitioning from non-PBS to PBS-subsidised supply - Grandfather arrangements | |